Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Blood|November 19, 2005
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow TransplantationStefan O Schönland, Henk Lokhorst, Agnes Buzyn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasiaSudhir Tauro, Charles Craddock, Karl Peggs, et al.
Blood Advances|September 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AMLNigel Russell, Jad Othman, Oliver Cumming, et al.
Bone Marrow Transplantation|September 20, 2019
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixaforCurly Morris, Christian Chabannon, Tamas Masszi, et al.
Haematologica|December 3, 2009
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Sandeep Nagra, Andrew Peniket, et al.
British Journal of Haematology|November 19, 2015
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocolsRachael Hough, Robert Danby, Nigel Russell, et al.
American Journal of Hematology|April 26, 2017
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
Journal of Clinical Apheresis|June 21, 2017
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancyKenneth W Douglas, Maria Gilleece, Patrick Hayden, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Haematologica|February 26, 2026
Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysisYu-Sung Chang, Yi-Wei Lee, Chieh-Yu Liu, et al.
Pageof 12